Loading clinical trials...
Loading clinical trials...
A Prospective Blinded Within-Subject Randomized Controlled Clinical Study to Investigate the Safety and Effectiveness of RECELL for Repigmentation of Stable Vitiligo Lesions
Conditions
Interventions
Control Intervention (UVB)
Investigational Interventions (Ablative Laser Resurfacing + RECELL + UVB)
Locations
12
United States
University of California, Irvine
Irvine, California, United States
University of California, Davis
Sacramento, California, United States
West Dermatology
San Diego, California, United States
DMR Research
Westport, Connecticut, United States
Skin Care Research, LLC
Hollywood, Florida, United States
Miami Dermatology and Laser Institute
Miami, Florida, United States
Start Date
September 10, 2020
Primary Completion Date
June 28, 2022
Completion Date
January 31, 2023
Last Updated
May 24, 2024
NCT07431177
NCT07352293
NCT07353801
NCT07437560
NCT07398807
NCT07357870
Lead Sponsor
Avita Medical
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions